A giant MS plaque mimicking PML during natalizumab treatment

Cary Twyman, Joseph R. Berger

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


We describe a patient with a giant MS plaque developing during natalizumab administration whose clinical presentations mimicked PML. This 27 year-old man developed new onset confusion, altered behavior, left hemianesthesia and worsening dysarthria, gait and balance with a new, large, rim-enhancing, temporoparietal subcortical lesion after four infusions of natalizumab. Cerebrospinal JC virus polymerase chain reaction was negative. No neutralizing antibody to natalizumab was detected. Following discontinuation of natalizumab, plasma exchange, and a single dose of 1000 mg of methylprednisolone, he demonstrated clinical and radiographic improvement. Distinguishing PML from MS may be very difficult in some instances. The frequency with which an aggressive demyelinating disorder due to MS occurs during treatment with natalizumab remains to be determined.

Original languageEnglish (US)
Pages (from-to)110-113
Number of pages4
JournalJournal of the neurological sciences
Issue number1-2
StatePublished - Apr 15 2010

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'A giant MS plaque mimicking PML during natalizumab treatment'. Together they form a unique fingerprint.

Cite this